Registered entities
Merrimack Pharmaceuticals, Inc.
Reg. No. 43210530United States
Merrimack Pharmaceuticals Inc
Reg. No. 1274792United States
Investor mix
11 investors on record; lead investors include TPG-Axon Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 27% |
| Private equity | 3 | 27% |
| Bank & private debt | 3 | 27% |
| Other / undisclosed | 2 | 18% |